Showing results (151-160 of 226) with videos related to

Sort By:
Pageof 23
NEJM Evidence|February 6, 2024
Validation of a Salivary miRNA Signature of Endometriosis - Interim DataSofiane Bendifallah, Yohann Dabi, Stéphane Suisse, et al.
Investigational New Drugs|May 11, 2010
A dose-escalation phase I trial of nimotuzumab, an antibody against the epidermal growth factor receptor, in patients with advanced solid malignanciesBenoit You, Anthony Brade, Joao M Magalhaes, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 16, 2019
Pharmacokinetic Study of Osimertinib in Cancer Patients with Mild or Moderate Hepatic ImpairmentEnrique Grande, R Donald Harvey, Benoit You, et al.
Clinical Biochemistry|April 29, 2008
Advantages of prostate-specific antigen (PSA) clearance model over simple PSA half-life computation to describe PSA decrease after prostate adenomectomyBenoit You, Paul Perrin, Gilles Freyer, et al.
American Journal of Clinical Oncology|March 2, 2011
A Phase II trial of erlotinib as maintenance treatment after gemcitabine plus platinum-based chemotherapy in patients with recurrent and/or metastatic nasopharyngeal carcinomaBenoit You, Christophe Le Tourneau, Eric X Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|April 30, 2008
Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre studyBenoit You, Brigitte Tranchand, Pascal Girard, et al.
Plos Pathogens|August 9, 2018
Human papillomavirus type 16 antagonizes IRF6 regulation of IL-1βMichelle Ainouze, Pauline Rochefort, Peggy Parroche, et al.
Virologie (Montrouge, France)|September 24, 2022
[Human retrovirus XMRV: The end of an exciting story?]Sonia Assil, Pierre-Adrien Bolze, Myriam Boukhali, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 7, 2025
Prognostic Value of a Joint K-PD Model With Tumor Size Dynamics and CA-125 Kinetics in Recurrent Ovarian Cancer Patients: BOLD Phase II GINECO StudyAurore Carrot, Pauline Corbaux, Olivier Colomban, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 1, 2026
Longitudinal kinetics of human epididymis protein 4 in recurrent advanced ovarian carcinoma treated with platinum-based chemotherapy: mathematical modeling and prognostic implicationsPetra Nardelli, Katharina Leitner, Aurore Carrot, et al.
Pageof 23